Press Release August 24, 2020 TDK Ventures backs handheld ultrasound imaging startup, Exo A pioneering health information and devices company, Exo (pronounced `Echo`) is TDK Ventures` first in the point-of-care diagnostics space. Additional investors include Action Potential Venture Capital, a Corporate VC arm of GlaxoSmithKline and Magnetar Capital, an affiliate of Fiscus Ventures and RIVC Ventures. Redwood City, California-based Exo develops miniaturized ultrasound devices for applications in emergency medicine, critical care, vascular, anesthesiology, tomography, precision endoscopy, non-invasive neuromodulation, and therapeutic delivery. TDK Corporation will provide assistance to Exo...
|
